Mr. Reistetter is currently a managing partner at Iron Path Capital and co-leads the firm’s private equity execution and leads Iron Path’s internal operations. Prior to founding Iron Path, Mr. Reistetter was a Principal with Quad-C where he spent nearly 14 years as a key leader or member on deal teams. Mr. Reistetter joined Quad-C in 2007 and was a Vice President from 2007-2013 and Principal from 2013-2021. Mr. Reistetter was one of two senior professionals that established the healthcare vertical at Quad-C. Mr. Reistetter also led the specialty chemicals vertical at Quad-C from 2014 – 2021.
Mr. Reistetter currently serves on the boards of Emergence Health, Versant Diagnostics, Capitol Pain Institute, and PureTech Scientific. He has an attributable track record from his nearly 14 years with Quad-C including investments in Boulder Scientific Company, Prism Vision Group, Retina Group of Washington, VMG Health, Compassion First, Dental Care Alliance, Towncare Dental, NuSil Technology and Royal Adhesives & Sealants.
Prior to joining Quad-C, he worked at JLL Partners where he evaluated and executed private equity investments in various industries, including industrials, healthcare, for-profit education, and specialty finance. Prior to JLL Partners, Mr. Reistetter was with J.P. Morgan Chase in the Leveraged Finance Group where he focused on providing senior and subordinated debt financing for a broad range of leveraged buyout transactions.
Mr. Reistetter holds a B.S. degree in Finance & Accounting from Ithaca College and an M.B.A. from Harvard Business School.